Connecting you to content on EBSCOhost

Works by Wingelhofer, Bettina

Results: 6

1

Emerging therapeutic targets in myeloproliferative neoplasms and peripheral T-cell leukemia and lymphomas.

Published in:

Expert Opinion on Therapeutic Targets, 2018, v. 22, n. 1, p. 45, doi. 10.1080/14728222.2018.1406924

By:

Orlova, Anna;
Wingelhofer, Bettina;
Neubauer, Heidi A.;
Maurer, Barbara;
Berger-Becvar, Angelika;
Keserű, György Miklós;
Gunning, Patrick T.;
Valent, Peter;
Moriggl, Richard

Publication type:

Article

2

STAT3/LKB1 controls metastatic prostate cancer by regulating mTORC1/CREB pathway.

Published in:

Molecular Cancer, 2023, v. 22, n. 1, p. 1, doi. 10.1186/s12943-023-01825-8

By:

Pencik, Jan;
Philippe, Cecile;
Schlederer, Michaela;
Atas, Emine;
Pecoraro, Matteo;
Grund-Gröschke, Sandra;
Li, Wen;
Tracz, Amanda;
Heidegger, Isabel;
Lagger, Sabine;
Trachtová, Karolína;
Oberhuber, Monika;
Heitzer, Ellen;
Aksoy, Osman;
Neubauer, Heidi A.;
Wingelhofer, Bettina;
Orlova, Anna;
Witzeneder, Nadine;
Dillinger, Thomas;
Redl, Elisa

Publication type:

Article

3

S171: HIGHER MDMX EXPRESSION WAS ASSOCIATED WITH HYPOMETHYLATING AGENT RESISTANCE AND WORSE SURVIVAL IN MYELODYSPLASTIC SYNDROME PATIENTS, INFERRING IT A POTENTIAL THERAPEUTIC TARGET.

Published in:

HemaSphere, 2023, v. 7, p. 1, doi. 10.1097/01.HS9.0000967596.07975.9f

By:

Wang, Yu‐Hung;
Lin, Chien‐Chin;
Yao, Chi‐Yuan;
Gurashi, Kristian;
Amaral, Fabio M. R.;
Nicosia, Luciano;
Wingelhofer, Bettina;
Batta, Kiran;
Wiseman, Daniel;
Hou, Hsin‐An;
Chou, Wen Chien;
Tien, Hwei‐Fang

Publication type:

Article

4

The JAK2/STAT5 signaling pathway as a potential therapeutic target in canine mastocytoma.

Published in:

Veterinary & Comparative Oncology, 2018, v. 16, n. 1, p. 55, doi. 10.1111/vco.12311

By:

Keller, Alexandra;
Wingelhofer, Bettina;
Peter, Barbara;
Bauer, Karin;
Berger, Daniela;
Gamperl, Susanne;
Reifinger, Martin;
Cerny-Reiterer, Sabine;
Moriggl, Richard;
Willmann, Michael;
Valent, Peter;
Hadzijusufovic, Emir

Publication type:

Article

5

STAT5 is Expressed in CD34+/CD38− Stem Cells and Serves as a Potential Molecular Target in Ph-Negative Myeloproliferative Neoplasms.

Published in:

Cancers, 2020, v. 12, n. 4, p. 1021, doi. 10.3390/cancers12041021

By:

Hadzijusufovic, Emir;
Keller, Alexandra;
Berger, Daniela;
Greiner, Georg;
Wingelhofer, Bettina;
Witzeneder, Nadine;
Ivanov, Daniel;
Pecnard, Emmanuel;
Nivarthi, Harini;
Schur, Florian K. M.;
Filik, Yüksel;
Kornauth, Christoph;
Neubauer, Heidi A.;
Müllauer, Leonhard;
Tin, Gary;
Park, Jisung;
de Araujo, Elvin D.;
Gunning, Patrick T.;
Hoermann, Gregor;
Gouilleux, Fabrice

Publication type:

Article

6

Fibroblast growth factor receptor 4: a putative key driver for the aggressive phenotype of hepatocellular carcinoma.

Published in:

Carcinogenesis, 2014, v. 35, n. 10, p. 2331, doi. 10.1093/carcin/bgu151

By:

Gauglhofer, Christine;
Paur, Jakob;
Schrottmaier, Waltraud C.;
Wingelhofer, Bettina;
Huber, Daniela;
Naegelen, Isabelle;
Pirker, Christine;
Mohr, Thomas;
Heinzle, Christine;
Holzmann, Klaus;
Marian, Brigitte;
Schulte-Hermann, Rolf;
Berger, Walter;
Krupitza, Georg;
Grusch, Michael;
Grasl-Kraupp, Bettina

Publication type:

Article